Finally, our findings highlight the importance of dietary FAs in maintaining body homeostasis and control the course of the disease, and suggest possible therapeutic use of a synthetic FABP4 inhibitor in GI disorders, particularly IBS. This evidence concerns the gene FABP4 and irritable bowel syndrome.